Detalhe da pesquisa
1.
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
Cytokine
; 177: 156543, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373365
2.
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Exp Parasitol
; 260: 108743, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513973
3.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768367
4.
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis.
Parasite Immunol
; 44(8): e12921, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437797
5.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968460
6.
Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection.
Parasitol Res
; 121(7): 2129-2140, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614147
7.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol
; 210(2-3): 133-147, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870453
8.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Cell Immunol
; 356: 104194, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32827943
9.
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Parasite Immunol
; 42(12): e12784, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772379
10.
An immunoproteomics approach to identify Leishmania infantum proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection.
Parasitology
; 147(9): 932-939, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32308186
11.
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
Exp Parasitol
; 216: 107941, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622940
12.
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
Parasitol Res
; 119(8): 2609-2622, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535734
13.
Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach.
Parasitology
; 146(11): 1467-1476, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142384
14.
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
Parasitology
; 146(3): 322-332, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30198459
15.
Leishmania infantum ß-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis.
Int J Mol Sci
; 20(8)2019 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013713
16.
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.
Cell Immunol
; 334: 61-69, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287082
17.
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Cell Immunol
; 331: 67-77, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871740
18.
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Cell Immunol
; 323: 59-69, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128045
19.
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis.
Cytokine
; 111: 131-139, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142534
20.
Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis.
Parasitology
; 145(6): 740-751, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113597